Loading…
Vivani Medical, Inc. is projected to rise to $1.61 by 2027, a +26% move from its current price of $1.28. VANI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.24 | $1.28 | $1.33 | +0.11% |
| Aug 5 | $1.22 | $1.28 | $1.35 | +0.22% |
| Aug 6 | $1.21 | $1.28 | $1.36 | +0.33% |
| Aug 7 | $1.20 | $1.29 | $1.38 | +0.44% |
| Aug 8 | $1.19 | $1.29 | $1.39 | +0.55% |
| Aug 9 | $1.18 | $1.29 | $1.40 | +0.66% |
| Aug 10 | $1.18 | $1.29 | $1.41 | +0.77% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.18 | $1.29 | $1.41 | +0.77% |
| Week 2 | $1.14 | $1.30 | $1.48 | +1.54% |
| Week 3 | $1.12 | $1.31 | $1.53 | +2.32% |
| Week 4 | $1.10 | $1.32 | $1.58 | +3.10% |
| Week 5 | $1.09 | $1.33 | $1.63 | +3.90% |
| Week 6 | $1.07 | $1.34 | $1.67 | +4.69% |
| Week 7 | $1.06 | $1.35 | $1.72 | +5.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that develops miniaturized and subdermal drug implants to treat chronic diseases. It uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical partners, to address causes of poor clinical outcomes in chronic disease treatment.
Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Vivani Medical, Inc. trades under the symbol VANI. The stock is currently priced at $1.26 per share, with a market capitalization of $108.66M and a rank of 4146.
The near-term forecast for 2026 shows a neutral sentiment, with an average price of $1.26, a range from $0.938 to $1.80, and a 0% ROI. The longer-run forecast turns bullish from 2027 onward, with the average price rising toward the long-run outlook and a maximum forecast of $24.98 by 2050.
A major floor 32.3% below — a decisive break under it would weaken the trend.
The nearest floor, 11.7% below — buyers have tended to step in here.
The nearest ceiling, 25.0% above — a clean break opens room to run.
A major ceiling 41.1% above — clearing it would confirm fresh momentum.
Key VANI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VANI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.29 | Sell | $1.30 | Sell |
| MA 10 | $1.33 | Sell | $1.32 | Sell |
| MA 20 | $1.37 | Sell | $1.32 | Sell |
| MA 50 | $1.27 | Buy | $1.29 | Sell |
| MA 100 | $1.23 | Buy | $1.27 | Buy |
| MA 200 | $1.30 | Sell | $1.27 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.15 | Neutral |
| Stoch RSI (14) | 13.82 | Buy |
| CCI (20) | -89.43 | Neutral |
| Williams %R (14) | -88.24 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -9.22 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 11.76 | Buy |
| TRIX (15) | 0.31 | Buy |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 34.31 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1.26 | Buy |
| ADX (14) | 11.34 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is bearish. RSI14 is 50, and the simple moving averages are SMA50 at $1.26 and SMA200 at $1.31.
Support is identified at $1.13 and resistance at $1.60. The 30-day price range extends from $0.9953 to $1.60.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.938 | $1.28 | $1.81 | 0% | Neutral | |
| $1.25 | $1.61 | $2.20 | +26% | Bullish | |
| $1.56 | $2.08 | $2.97 | +62% | Bullish | |
| $1.72 | $2.37 | $3.51 | +85% | Bullish | |
| $1.84 | $2.59 | $3.96 | +102% | Bullish | |
| $1.88 | $2.72 | $4.26 | +112% | Bullish | |
| $1.71 | $2.53 | $4.06 | +98% | Bullish | |
| $1.93 | $2.92 | $4.78 | +128% | Bullish | |
| $2.29 | $3.53 | $5.89 | +176% | Bullish | |
| $2.50 | $3.94 | $6.68 | +208% | Bullish | |
| $2.77 | $4.79 | $8.73 | +274% | Bullish | |
| $5.94 | $12.09 | $24.47 | +844% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.938 | $1.28 | $1.52 | +0.00% |
| September 2026 | $1.12 | $1.33 | $1.64 | +3.84% |
| October 2026 | $1.18 | $1.41 | $1.76 | +6.39% |
| November 2026 | $1.17 | $1.41 | $1.78 | -0.17% |
| December 2026 | $1.17 | $1.42 | $1.81 | +0.63% |
Click any year to see its month-by-month VANI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Vivani Medical, Inc.'s 2026 outlook centres on $1.28, within a $0.938 to $1.81 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, VANI could reach as high as $2.20, with a base case around $1.61 and support toward $1.25 — roughly +26% from $1.28. Momentum favours further upside here.
Expect VANI to range from $1.56 to $2.97 through 2028. The $2.08 average target implies a +62% move from current prices. That is up +29% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The VANI price prediction for 2029 points to an average of $2.37 (low $1.72, high $3.51) — a potential gain of +85% on today's $1.28. Momentum favours further upside here.
In 2030, VANI is projected to trade between $1.84 and $3.96, averaging $2.59 — a potential gain of +102% from today's $1.28. That is up +9% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Vivani Medical, Inc.'s 2031 outlook centres on $2.72, within a $1.88 to $4.26 range. That is up +5% on the projected 2030 average. That marks a +112% change versus current levels. Momentum favours further upside here.
By 2032, VANI could reach as high as $4.06, with a base case around $2.53 and support toward $1.71 — roughly +98% from $1.28. Buyers look set to stay in control over this stretch.
Expect VANI to range from $1.93 to $4.78 through 2033. The $2.92 average target implies a +128% move from current prices. That is up +15% on the projected 2032 average. Momentum favours further upside here.
The VANI price prediction for 2034 points to an average of $3.53 (low $2.29, high $5.89) — a potential gain of +176% on today's $1.28. Buyers look set to stay in control over this stretch.
In 2035, VANI is projected to trade between $2.50 and $6.68, averaging $3.94 — a potential gain of +208% from today's $1.28. That is up +11% on the projected 2034 average. Momentum favours further upside here.
Vivani Medical, Inc.'s 2040 outlook centres on $4.79, within a $2.77 to $8.73 range. That is up +22% on the projected 2035 average. That marks a +274% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, VANI could reach as high as $24.47, with a base case around $12.09 and support toward $5.94 — roughly +844% from $1.28. Momentum favours further upside here.
Investing $1,000 in VANI today (≈ 781.25 VANI) could be worth
$9,441.44
+$8,441.44 (+844%) by 2050 · US Dollar
Based on the average projected VANI price of $12.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VANIwould be worth at today's price.
$1,000 invested in VANI on Jul 31, 2025 (≈ 746.268638 VANI) would be worth
$955.22
-$44.78 (-4.5%) today · 0.96× · US Dollar
Based on a VANI entry price of $1.34 vs. today's $1.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.28 | $1,000 | +0.0% |
| 1 month ago | $1.23 | $1,040.65 | +4.1% |
| 3 months ago | $1.36 | $941.18 | -5.9% |
| 6 months ago | $1.47 | $870.75 | -12.9% |
| 1 year ago | $1.34 | $955.22 | -4.5% |
| All time (5.0y) ago | $11.13 | $115 | -88.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VANI forecast.
Our base-case forecast reaches $2.60 around 2031.
Implied market cap at $2.60: $224.21M
The multi-year forecast shows a shift from neutral in 2026 to bullish in the following years, with 2027 avg $1.59 and a steady ascent to 2030 avg $2.58 and 2035 avg $3.93. By 2040, the average price is forecast at $4.71, and by 2050 the average price reaches $12.12 with a max of $24.98. Return-on-investment rises accordingly, reaching 104.8% in 2030, 273.8% in 2040, and 862% in 2050.
Key milestones along the way include 2030 avg $2.58, 2040 avg $4.71, and 2050 avg $12.12, with corresponding max forecasts up to $3.98 (2030) and $24.98 (2050). The overarching outlook is bullish from 2027 onward, but these figures are estimates and not guarantees, subject to clinical progress, market conditions, and other factors.
Tap a question to reveal the answer.
2030 forecast: min $1.81, avg $2.58, max $3.98; ROI 104.8%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with averages rising to $12.12 by 2050 and a max of $24.98, but these are estimates and not guarantees.
Yes, the 2050 max forecast is $24.98, which exceeds $10.0, indicating potential to surpass $10 if the forecast holds. Earlier years show smaller upside (e.g., 2040 max $8.72, 2035 max $6.76).
Near-term sentiment for 2026 is NEUTRAL; RSI 14 is 50. The 30-day range is $0.9953 to $1.60, with support at $1.13 and resistance at $1.60.
Vivani Medical, Inc. Community Discussion
0Share your Vivani Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.